Literature DB >> 16730717

Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer.

Niroshani Pathirage1, Lisa A Di Nezza, Lois A Salmonsen, Tom Jobling, Evan R Simpson, Colin D Clyne.   

Abstract

Quantitative polymerase chain reaction analysis of a panel of normal and malignant endometrial tissues revealed significant expression of both aromatase and estrogen receptor alpha in low-grade tumors, suggesting that local estrogen synthesis and action might contribute to the proliferation of these tumors.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16730717     DOI： 10.1016/j.fertnstert.2005.12.057

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  8 in total

Review 1.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

2.  The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.

Authors:  Maša Sinreih; Tamara Knific; Maja Anko; Neli Hevir; Katja Vouk; Aleš Jerin; Snježana Frković Grazio; Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2017-06-23       Impact factor: 5.810

3.  Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells.

Authors:  Maria M Szwarc; Ramakrishna Kommagani; Vasanta Putluri; Julien Dubrulle; Fabio Stossi; Michael A Mancini; Cristian Coarfa; Rainer B Lanz; Nagireddy Putluri; Francesco J DeMayo; John P Lydon; Bert W O'Malley
Journal:  Sci Rep       Date:  2018-09-03       Impact factor: 4.379

4.  Genetic variants in ER cofactor genes and endometrial cancer risk.

Authors:  Yuqing Li; Hui-Qi Low; Jia Nee Foo; Hatef Darabi; Kristjana Einarsdόttir; Keith Humphreys; Amanda Spurdle; Douglas F Easton; Deborah J Thompson; Alison M Dunning; Paul D P Pharoah; Kamila Czene; Kee Seng Chia; Per Hall; Jianjun Liu
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

5.  The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.

Authors:  Lena Secky; Martin Svoboda; Lukas Klameth; Erika Bajna; Gerhard Hamilton; Robert Zeillinger; Walter Jäger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-13

Review 6.  Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human.

Authors:  Atish Mukherjee; Paula Amato; D Craig Allred; Francesco J DeMayo; John P Lydon
Journal:  Nucl Recept Signal       Date:  2007-11-30

7.  Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology.

Authors:  Katarzyna Jarzabek; Mariusz Koda; Malgorzata Walentowicz-Sadlecka; Marek Grabiec; Piotr Laudanski; Slawomir Wolczynski
Journal:  Tumour Biol       Date:  2013-07-20

Review 8.  The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.

Authors:  Tea Lanišnik Rižner; Theresia Thalhammer; Csilla Özvegy-Laczka
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.